Abbott Laboratories (ABT): Director sold ~$337K

~$337K

Approx. value · 2,600 sh @ $129.66

34K

Holds after · shares reported

Traded

Apr 30, 2025

Filed

May 2, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

1. Feb 13, 2025CongressDisclosed purchase of ABT — reported range $1,001 - $15,000
2. Feb 24, 2025CongressDisclosed partial sale of ABT — reported range $1,001 - $15,000
3. Mar 3, 2025Insider · 5 peopleInsiders: 5 sales (~$549K)
4. Mar 3, 2025CongressDisclosed purchase of ABT — reported range $1,001 - $15,000
5. Mar 6, 2025InsiderOfficer sold ~$12.2M of ABT shares in the open market
6. Mar 6, 2025CongressDisclosed partial sale of ABT — reported range $1,001 - $15,000
7. Mar 7, 2025InsiderOfficer sold ~$27K of ABT shares in the open market
8. Mar 20, 2025Congress · 1 personMembers of Congress: 2 purchases
9. Mar 24, 2025FDAFDA device clearance: Alinity m BKV
10. Apr 4, 2025FDAFDA device clearance: JETi Hydrodynamic Thrombectomy System
11. Apr 21, 2025CongressDisclosed sale of ABT — reported range $1,001 - $15,000
12. Apr 25, 2025FDAFDA device clearance: Amulet™ Steerable Delivery Sheath
13. Apr 28, 2025FDARecall: Alinity m Resp-4-Plex AMP Kit, List Number 09N79-096, a multiplex real-time reverse transcription (RT) polymerase chain reaction (PCR) test intended for the si…
14. Apr 28, 2025FDARecall: Alinity m Resp-4-Plex Amplification (AMP) Kit (CE), List Number 09N79-090, a multiplex real-time reverse transcription (RT) polymerase chain reaction (PCR) tes…
15. Apr 30, 2025 · this disclosureInsiderDirector sold ~$337K of ABT shares in the open market

What came next

1. May 12, 2025CongressDisclosed sale of ABT — reported range $50,001 - $100,000
2. May 20, 2025FDAFDA device clearance: ViewFlex™ X ICE Catheter, Sensor Enabled™
3. May 23, 2025FDAFDA device clearance: ViewFlex™ Xtra ICE Catheter; ViewFlex™ Eco Reprocessed ICE Catheter; Advisor™ HD Grid Mapping Catheter, Sensor Enabled™; Advisor™ HD Grid X Mapping Catheter, S…
4. May 23, 2025FDAFDA device approval: Tendyne Transcatheter Mitral Valve System
5. May 27, 2025FDAFDA device clearance: Disposable RF Electrode (RFDE-5/RFDE-10/RFDE-15/RFDE-20)
6. Jun 20, 2025FDAFDA device clearance: Alinity i Rubella IgG
7. Jun 24, 2025CongressDisclosed purchase of ABT — reported range $1,001 - $15,000
8. Jul 1, 2025FDAFDA device clearance: Alinity m CMV
9. Jul 9, 2025FDAFDA device clearance: ARCHITECT iGentamicin
10. Jul 10, 2025CongressDisclosed sale of ABT — reported range $1,001 - $15,000
11. Jul 18, 2025CongressDisclosed partial sale of ABT — reported range $1,001 - $15,000
12. Jul 21, 2025CongressDisclosed purchase of ABT — reported range $1,001 - $15,000
13. Jul 25, 2025FDAFDA device clearance: Hi-Torque Command 14 ST Guide Wire and Hi-Torque Command 14 MT Guide Wire
14. Jul 28, 2025FDAFDA device clearance: Alinity m EBV (09N43-095)
15. Jul 30, 2025FDAFDA device clearance: EnSite™ X EP System
16. Aug 8, 2025InsiderCFO sold ~$747K of ABT shares in the open market

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Abbott Laboratories

For Abbott Laboratories, OQRO holds 5 insider filings (SEC Form 4 or Form 144), 6 Congress trade reports and 59 fund holdings reports (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its ABT page.

How this filing works

• SEC Form 4
• Open-market purchase
• Rule 10b5-1 trading plans

Other disclosures at Abbott Laboratories

• House Clerk periodic transaction reportOct 30, 2026
• House Clerk periodic transaction reportOct 27, 2026
• House Clerk periodic transaction reportOct 12, 2026
• SEC Form 4Sep 3, 2026
• SEC Form 144Sep 2, 2026
• SEC Form 4Aug 27, 2026

Everything OQRO holds on this company is on its ABT page.